Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products

Author (Corporate)
Publisher
Publication Date 2012
Content Type

The European Medicines Agency (EMA), in February 2012, published a guideline advising pharmaceutical companies how to integrate studying the role of genetic variability between patients during the development of medicines.

Pharmacogenomics is the study of how the variability of the expression of genes between people leads to differences in susceptibility to disease and responses to medicines.

Source Link http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/02/WC500121954.pdf
Related Links
EMA: News, 10.2.12: European Medicines Agency publishes guideline on use of pharmacogenetics in evaluating pharmacokinetics of medicines http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/02/news_detail_001434.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp
Subject Categories ,
Countries / Regions